By Michael Erman and Mrinalika Roy Feb 3 (Reuters) - Pfizer on Tuesday released trial data on a high-profile obesity drug from its recent $10 billion Metsera purchase that raises questions about its ...

AI is changing everything at the top consulting firms. McKinsey and others are racing to both adopt AI internally and advise clients to do the same. Now, firms are requiring would-be consultants to ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Leadership roles require strategy and business sense more than daily operational know-how, ...

In a recent interview with Schwab Network, analysts discussed the potential impact of Microsoft Corporation (NASDAQ: MSFT) Azure on Alphabet Inc.’s (NASDAQ: GOOGL) Google AI business and why they ...

Chris Mooney is a Pulitzer Prize-winning journalist and a CNN Climate contributor. He is currently a professor of practice in the Environmental Institute at the University of Virginia. Planet-warming ...

Once a breakout non-fungible token (NFT) project during the 2021 crypto boom, Pudgy Penguins is turning to real-world visibility with a high-profile ad placement at the Las Vegas Sphere during ...

Advanced Micro Devices AMD shares have jumped 70.3% in the past year, outperforming the Zacks Computer and Technology sector’s 24.7% return and the Zacks Computer – Integrated Systems industry’s ...

A company with $20 billion in annual revenue can’t commit $1.4 trillion to capital infrastructure. It’s simple math: by the end of 2026, market pressure is likely to push OpenAI toward scaling back ...

Marvell clearly has visibility into big financial opportunities, but analysts wonder about its competitive positioning and the impact of a newly announced deal Marvell's stock was up about 8% on ...

Almost exactly one year ago, Janux Therapeutics unveiled early data for its investigational T-cell engager that wowed investors and analysts alike. But the biotech’s newest update has failed to garner ...

Concerns about the steep valuations of artificial intelligence (AI) stocks and a questionable outlook for an interest rate cut in December weighed on investor sentiment in recent trading sessions. For ...